ECSP045242A - Ambroxol for the treatment of painful conditions in the oral and pharyngeal cavity - Google Patents

Ambroxol for the treatment of painful conditions in the oral and pharyngeal cavity

Info

Publication number
ECSP045242A
ECSP045242A EC2004005242A ECSP045242A ECSP045242A EC SP045242 A ECSP045242 A EC SP045242A EC 2004005242 A EC2004005242 A EC 2004005242A EC SP045242 A ECSP045242 A EC SP045242A EC SP045242 A ECSP045242 A EC SP045242A
Authority
EC
Ecuador
Prior art keywords
ambroxol
oral
treatment
painful conditions
pharyngeal cavity
Prior art date
Application number
EC2004005242A
Other languages
Spanish (es)
Inventor
Anke Esperester
Uwe Pschorn
Jean-Michael Vix
Original Assignee
Boehringer Ingelheim Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=27740434&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ECSP045242(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Boehringer Ingelheim Pharma filed Critical Boehringer Ingelheim Pharma
Publication of ECSP045242A publication Critical patent/ECSP045242A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/136—Amines having aromatic rings, e.g. ketamine, nortriptyline having the amino group directly attached to the aromatic ring, e.g. benzeneamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/4709—Non-condensed quinolines and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/04—Drugs for disorders of the respiratory system for throat disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A61P29/02—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID] without antiinflammatory effect
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Virology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pain & Pain Management (AREA)
  • Pulmonology (AREA)
  • Communicable Diseases (AREA)
  • Neurosurgery (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Oncology (AREA)
  • Otolaryngology (AREA)
  • Neurology (AREA)
  • Emergency Medicine (AREA)
  • Rheumatology (AREA)
  • Zoology (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

La invención se refiere a la utilización de Ambroxol y sus sales farmacológicamente compatibles para la prepara­ción de un medicamento para el tratamiento de estados dolorosos en la cavidad bucal y faríngea.The invention relates to the use of Ambroxol and its pharmacologically compatible salts for the preparation of a medicament for the treatment of painful conditions in the oral and pharyngeal cavity.

EC2004005242A 2002-02-27 2004-08-20 Ambroxol for the treatment of painful conditions in the oral and pharyngeal cavity ECSP045242A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE10208313A DE10208313A1 (en) 2002-02-27 2002-02-27 Ambroxol for the treatment of painful conditions in the mouth and throat

Publications (1)

Publication Number Publication Date
ECSP045242A true ECSP045242A (en) 2004-09-28

Family

ID=27740434

Family Applications (1)

Application Number Title Priority Date Filing Date
EC2004005242A ECSP045242A (en) 2002-02-27 2004-08-20 Ambroxol for the treatment of painful conditions in the oral and pharyngeal cavity

Country Status (21)

Country Link
EP (1) EP1480626A1 (en)
JP (1) JP2005518435A (en)
KR (1) KR20040084944A (en)
CN (1) CN1638749A (en)
AR (1) AR038698A1 (en)
AU (1) AU2003210345B2 (en)
BR (1) BR0308038A (en)
CA (1) CA2477105A1 (en)
DE (1) DE10208313A1 (en)
EC (1) ECSP045242A (en)
IS (1) IS7417A (en)
MX (1) MXPA04008220A (en)
MY (1) MY144781A (en)
PE (1) PE20030830A1 (en)
PL (1) PL371584A1 (en)
RU (1) RU2311176C2 (en)
TW (1) TW200306804A (en)
UA (1) UA86741C2 (en)
UY (1) UY27679A1 (en)
WO (1) WO2003072094A1 (en)
ZA (1) ZA200405635B (en)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10332486A1 (en) * 2003-07-16 2005-02-10 Boehringer Ingelheim Pharma Gmbh & Co. Kg Ambroxol for the treatment of acute pain
JP2005120063A (en) * 2003-10-14 2005-05-12 Boehringer Ingelheim Pharma Gmbh & Co Kg Ambroxol for the treatment of inflammation in the pharynx
ITMI20032462A1 (en) * 2003-12-16 2005-06-17 Advance Holdings Ltd METHOD TO PREPARE A CARAMEL CONTAINING AMBROXOLO AND THE CANDY SO OBTAINED
DE102004021992A1 (en) * 2004-05-03 2005-11-24 Boehringer Ingelheim Pharma Gmbh & Co. Kg Topical preparation containing ambroxol
JP2007084471A (en) * 2005-09-21 2007-04-05 Sunstar Inc Composition for oral cavity and method of selecting product for oral cavity
EP2015761A4 (en) * 2006-03-29 2009-07-29 Naveh Pharma 1996 Ltd METHODS AND COMPOSITION FOR THE TREATMENT OF THROAT SORE
JP5765934B2 (en) * 2009-12-28 2015-08-19 サンスター株式会社 Oral composition
JP6171683B2 (en) * 2012-08-03 2017-08-02 大正製薬株式会社 Solid preparation
CN105769908B (en) * 2016-05-06 2019-03-01 湖北凤凰白云山药业有限公司 A kind of drug of preventing phlegm from forming and stopping coughing and preparation method thereof
EP3538083B1 (en) 2016-11-14 2024-07-10 NeuVision Development LLC Formulations for the treatment of ocular surface diseases and related methods
CN106727621A (en) * 2016-11-22 2017-05-31 郑州仁宏医药科技有限公司 A kind of Western medicine powder for treating toothache
JP6844394B2 (en) * 2017-04-14 2021-03-17 大正製薬株式会社 Solid composition
EP3415143A1 (en) * 2017-06-16 2018-12-19 Kai-Uwe Kern Bromhexine for the treatment of pain
JP2023010636A (en) * 2021-07-07 2023-01-20 大正製薬株式会社 Pharmaceutical composition

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3034975C2 (en) * 1980-09-17 1986-11-27 Dr. Karl Thomae Gmbh, 7950 Biberach Drug combination used to treat infectious respiratory diseases
DE3432411A1 (en) * 1983-09-17 1985-04-11 Dr. Karl Thomae Gmbh, 7950 Biberach ANTIADHAESIVE PROHYLACTICA AND MEDICINAL PRODUCTS CONTAINING A SECRETOLYTICALLY EFFECTIVE BENZYLAMINE DERIVATIVE
DE3445226A1 (en) * 1983-12-14 1985-08-01 Reifenrath, Rainer Richard Otto, Dr.med., 7920 Heidenheim Pharmaceutical product for the treatment and prophylaxis of infections and of coughs and obstructive airway disorders
US5122540A (en) * 1986-02-28 1992-06-16 W. Keith R. Watson Method and composition for treating warts and throat soreness with DMSO and citric acid
US5458879A (en) * 1994-03-03 1995-10-17 The Procter & Gamble Company Oral vehicle compositions
DE4415553A1 (en) * 1994-05-03 1995-11-09 Behringwerke Ag Use of deoxyspergualin to prepare medicament
AU717764B2 (en) * 1996-05-02 2000-03-30 Taisho Pharmaceutical Co., Ltd. Suspension of sparingly water-soluble acidic drug
DE19933148A1 (en) * 1999-07-20 2001-01-25 Boehringer Ingelheim Int Lozenge containing ambroxol
JP2001151677A (en) * 1999-11-26 2001-06-05 Taisho Pharmaceut Co Ltd Pharyngeal composition
RU2169557C1 (en) * 1999-12-22 2001-06-27 Александр Афанасьевич Яремчук Ambroxol syrup for treatment of patients with bronchopulmonal diseases
DE20102817U1 (en) * 2000-02-23 2001-06-07 Bolder Arzneimittel GmbH, 50968 Köln Lozenges and chewing pills with cyclodextrin
US6391886B1 (en) * 2000-12-04 2002-05-21 The Procter & Gamble Company Oral compositions having improved consumer aesthetics

Also Published As

Publication number Publication date
DE10208313A1 (en) 2003-09-11
UA86741C2 (en) 2009-05-25
ZA200405635B (en) 2005-05-31
BR0308038A (en) 2004-12-28
PL371584A1 (en) 2005-06-27
AU2003210345B2 (en) 2009-01-29
IS7417A (en) 2004-08-19
MY144781A (en) 2011-11-15
AR038698A1 (en) 2005-01-26
CN1638749A (en) 2005-07-13
MXPA04008220A (en) 2004-11-26
CA2477105A1 (en) 2003-09-04
RU2004129284A (en) 2005-06-10
KR20040084944A (en) 2004-10-06
JP2005518435A (en) 2005-06-23
EP1480626A1 (en) 2004-12-01
WO2003072094A1 (en) 2003-09-04
PE20030830A1 (en) 2003-10-31
UY27679A1 (en) 2003-09-30
TW200306804A (en) 2003-12-01
RU2311176C2 (en) 2007-11-27
AU2003210345A1 (en) 2003-09-09

Similar Documents

Publication Publication Date Title
ECSP045242A (en) Ambroxol for the treatment of painful conditions in the oral and pharyngeal cavity
ECSP045069A (en) USE OF FLIBANSERINE IN THE TREATMENT OF SEXUAL DISORDERS
AR045972A1 (en) FORMULATIONS OF RELEASE OF SUSTAINED LIBERATION WITH EFFECTIVENESS OF 24 HOURS
CY1114448T1 (en) PHARMACEUTICAL COMPOSITIONS AND USE OF THESE IN WOMEN'S SEXUAL INTERFERENCE
FR2878159B1 (en) ORAL MEDICATION WITH MODIFIED RELEASE OF AT LEAST ONE ACTIVE PRINCIPLE IN MULTIMICROCAPSULAR FORM
CL2008000896A1 (en) Periodic oral care maintaining composition comprising a basic amino acid; use in the therapeutic treatment of the buccal surface.
EA200802208A1 (en) APPLICATION OF FLIBANSTERIN FOR THE TREATMENT OF DISEASES OF THE SEXUAL TREATMENT IN THE POST-CLIMACTERNIC PERIOD
PA8573101A1 (en) TREATMENT AND PREVENTION OF OSTEOPOROSIS
AR109644A2 (en) PRADOFLOXACINE AND PHARMACEUTICAL COMPOSITION FOR THE SYSTEMIC TREATMENT OF BACTERIAL DISEASES IN THE ORAL CAVITY
EP1781277A4 (en) COMBINED COMPOSITION
PE20090625A1 (en) PHARMACEUTICAL COMPOSITION CONTAINING BUPRENORPHINE AND NALMEFENE
ECSP077843A (en) PRURITE TREATMENT OR PREVENTION
PE20061314A1 (en) ASSOCIATION BETWEEN FERROQUINE AND A DERIVATIVE OF ARTEMISININ FOR THE TREATMENT OF MALARIA
BRPI0409175A (en) oral pharmaceutical preparation for proton pumping antagonists
PA8800601A1 (en) CRYSTAL CHEMOTHERAPEUTIC PRODUCTS
PA8800401A1 (en) CRYSTAL CHEMOTHERAPEUTIC PRODUCTS
BR0309808A (en) Combination for the treatment of airway disorders
PA8624501A1 (en) PIPERAZINAS DERIVED FROM UREA FOR THE TREATMENT OF ENDOMETROSIS
AR077451A1 (en) USE OF BENZIDAMINE IN THE TREATMENT OF P40 DEPENDENT DISEASES
GT200300020A (en) GENETIC POLYMORPHISMS IN THE PREPROTAQUIQUININE GEN
GT200200002A (en) USE OF CHROMANS
BRPI0412681A (en) pharmaceutical composition for nasal administration of piribedil
GT200500267A (en) USE OF EPOTILONES IN THE TREATMENT OF BONE METASTASIS
UY28771A1 (en) PIPERAZINAS DERIVED FROM UREA FOR THE TREATMENT OF ENDOMETROSIS.
UY29303A1 (en) MEDICATIONS FOR THE TREATMENT OR PREVENTION OF FIBROTIC DISEASES